Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Álvaro Rodríguez-LescureJavier GallegoPilar Garcia-AlfonsoBartomeu MassutiRaúl MárquezLourdes CalvoPedro Sánchez-RoviraAntonio AntónJosé Ignacio ChacónEva CiruelosJose Juan PonceAna SantaballaManuel Valladares-AyerbesMaría Rosario DueñasVicente AlonsoJorge AparicioSara EncinasLuis RoblesMaría José EscuderoRosalía CaballeroSusana BezaresJuan de la Haba-RodriguezPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
ClinicalTrials.gov Identifier: NCT01733628.